Hugan Qingzhi tablet ameliorates hepatic steatosis by activating AMPK and PPARα pathway in L-02 cell

来源 :2015广东省药师周大会 | 被引量 : 0次 | 上传用户:deskleg
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Ethnopharmacological relevance: Hugan Qingzhi Tablet (HQT) is composed of five Chinese herbs,i.e.Rhizoma alismatis,Fructus Crataegi,Cattail Pollen,Lotus Leaf,Panax notoginseng.It has been used in prevention and treatment of non-alcoholic fatty liver (NAFLD).Aim of the study: This manuscript aims to evaluate the effect of HQT medicated serum on hepatic steatosis by using in vitro experiments on cells and explore the relevant mechanisms with method of serum pharmacology.Materials and method: The L-02 cells and HepG2 cells with FFA-induced hepatic steatosis model were used to investigate whether HQT could attenuate lipid accumulation and oxidative stress and explore the possible mechanisms.High-performance liquid chromatography (HPLC) was used to study components in serum contained HQT.Intracellular lipid droplets and triglyceride (TG) were detected to evaluate the lipid-lowing effect of HQT.Lactate dehydrogenase (LDH),aspartate aminotransferase (AST),alanine aminotransferase (ALT) in culture media were measured to evaluate protective effects of HQT on hepatic cells.Total antioxidant capacity (T-AOC),malonaldehyde (MDA),superoxide dismutase (SOD) and glutathione (GSH) were detected to measure antioxidant effects of HQT.Adiponection expression was investigated to evaluate the effect of HQT on adipocytokines.Furthermore,western blot and quantitative reverse transcription polymerase chain reaction (qRT -PCR) were performed to explore the relevant mechanisms of lipid metabolism of HQT.The phosphorylation levels of AMP-activated protein kinase (AMPK) and sterol regulatory element-binding protein 1 (SREBP-1) expression were measured to evaluate the effect of HQT on hepatic lipogenesis.Peroxisome proliferator activated receptor-α (PPARα),carnitine palmitoyltransferase 1 (CPT-1A) and acetyl-CoA oxidase 1 (ACOX1) expression were measured to evaluate the effect of HQT on hepatic lipolysis.Results: HQT medicated serum alleviated the accumulation of lipid droplets and decreased the cellular TG content in L02 cells and HepG2 cells.They caused significant reductions in contents of LDH,AST,ALT and MDA as well as significant increase in T-AOC activity in the culture media.They also caused increase in levels of GSH and SOD in FFA-induced steatosis L-02 and HepG2 cells.Furthermore,HQT medicated serum enhanced adiponection expression with a concentration-dependent manner and reversed the FFA-induced decrease in the phosphorylation levels of AMPK and PPARα,CPT-1,ACOX1 as well as decreased the expression of SREBP-1.Conclusion: The HQT medicated serum inhibited lipid accumulation and oxidative stress which might be through the activation of AMPK and PPARα pathway.
其他文献
目的:研究吉西他滨在不同时间点给药对于光制改变肝癌小鼠的治疗效果比较.方法:建立光制改变的肝癌小鼠模型,在8am,14pm,20pm,2am给予固定剂量的吉西他滨治疗,比较疗效的区别.结果:吉西他滨对于光制改变的肝癌小鼠具有治疗作用,光镜下可见吉西他滨治疗组小鼠的肺肝肾损伤较肝癌模型组减轻,肝肾功能改善(P<0.05,8am、14pm、20pm组vs.肝癌模型组;P<0.01,2am组vs.肝癌模
目的:研究金属有机骨架MIL-53作为药物载体装载抗肿瘤药5-FU,及其体外释药和MIL-53的细胞相容性.方法:以水热法制备金属有机骨架MIL-53,并通过透射电镜(TEM),X-射线粉末衍射(XRD),红外光谱(IR),热重分析(TG)对所得样品进行表征.以5-FU为模型药物,研究MIL-53载药、体外释药和载体MIL-53的细胞相容性.结果:XRD谱图与IR谱图确定了样品MIL-53的结构,
RNAi technology is taking strong position among the key therapeutic modalities,with dozens of siRNA-based programs entering and successfully progressing through clinical stages of drug development.To
会议
目的:观察P2Y12、P2Y1和ITGB3基因多态性对PCI术后受阿司匹林和氯吡格雷抗血小板效应的影响.方法:520例冠心病患者经PCI术后接受阿司匹林和氯吡格雷联合抗血小板治疗.所有患者行PCI术前每天口服给予氯吡格雷负荷剂量300mg和阿司匹林负荷剂量100mg,术后改为每天口服氯吡格雷75mg,维持剂量,服用6个月以上,口服阿司匹林100mg,维持剂量,服用1年,如患者出现胃出血等不宜服用时
目的:考察中国异基因造血干细胞移植(Allogeneic Hematopoietic Stem Cells Transplantation,allo-HSCT)术后患者环孢素A(Cyclosporine A,CsA)群体药代动力学(population pharmacokinetics,PPK)特征,为临床设计个体化给药方案提供参考.方法:回顾性收集32名allo-HSCT术后使用CsA治疗患者常
目的:研究南蛇藤(Celastrus orbiculatus Thunb.)叶子降血糖有效部位的化学成分.方法:采用柱色谱和薄层色谱分离南蛇藤叶子降血糖有效部位中的化学成分;用IR、MS、NMR等波谱技术鉴定结构.结果:分离并鉴定了7个化合物,分别为山奈酚(1)、槲皮素(2)、山奈酚-7-O-α-L-鼠李糖苷(3)、山奈酚-3,7-二-O-α-L-鼠李糖苷(4)、槲皮素-3-O-β-D-葡萄糖苷(
目的:建立双乌宣痹颗粒的质量标准方法:采用TLC法对双乌宣痹颗粒中青蒿、制川乌、白芍等药材进行定性鉴别,采用HPLC法测定双乌宣痹颗粒中芍药苷的含量.结果:薄层色谱斑点清晰、分离效果好、且阴性无干扰.芍药苷在0.32~10.10μg范围呈现良好的线性关系(r=0.9998),平均回收率97.21%,RSD为2.56%.结论:该方法准确可靠、专属性强、重复性好,可以作为控制双乌宣痹颗粒质量的有效方法
Eclipta prostrata (EP) is often prescribed in combination with glucocorticoid to treat glomerular nephritis,nephrotic syndrome,and IgA nephropathy in clinical practice of Traditional Chinese Medicine.
目的:研究国产坎地沙坦酯片的人体生物等效性.方法:30名男性健康志愿者按开放、随机、单中心、单剂量三周期三制剂二重双交叉设计,分别口服受试制剂A、B和参比制剂各8mg,并采集48h内动态血标本,用高效液相色谱-串联质谱法测定血浆中坎地沙坦浓度,计算药动学参数,并判定三种制剂的生物等效性.结果:受试制剂A、B和参比制剂的主要药动学参数Cmax分别为(92.24±29.15)μg·L-1、(94.72
目的:利用循证药学方法研究清洁手术预防使用抗菌药物能否降低术后切口感染率.方法:计算机检索MEDLINE、BIOSIS Previews、Springer、中国生物医学文献数据库、康健临床决策循证数据库FEBM、中国期刊全文数据库、万方-医药期刊全文数据库,收集清洁手术预防使用抗菌药物的临床随机对照研究,筛选、评价文献质量并提取有效数据进行荟萃(meta)分析.结果:共纳入符合标准的文献10篇,荟